Rábago AJ, Asz SD, López L, Baquera J, Solloa ME, Arenas R, Jáuregui CL

Language: Spanish
References: 20
Page: 343-346
PDF size: 221.96 Kb.

ABSTRACT

Leishmaniasis is considered a chronic disease produced by a protozoa of the gender Leishmania which can affect skin, mucous membranes and internal organs. The most common presentation in our country is the cutaneous form and the state of Oaxaca is considered an endemic area. We communicate the clinical case of a 31 year-old male patient with the antecedent from a trip to Oaxaca and the later appearance in the right forearm of two ulcerated nodular lesions of chronic evolution. Histopathology showed a granulomatous reaction with amastygotes. Oral ketoconazole was initiated with total resolution in four weeks.

REFERENCES

1. Arenas R. Atlas de dermatología: diagnóstico y tratamiento. México: Interamericana-McGraw Hill, 2005.

2. OMS. Leishmaniasis. Serie de Informes Técnicos Núm. 701. Ginebra, 1984.

3. WHO. Control of the Leishmaniasis. Technical Report Series (793) of the WHO Expert Committee 1990.

4. Córdova-Uscanga C, Albertos-Alpuche NE, Andrade-Narváez FJ, Canto-Lara SB. Leishmaniasis: estudio epidemiológico preliminar en una localidad de la zona endémica del estado de Tabasco. Salud Publica Mex 1993;35:345-50.

5. Frías-Salcedo JA. Leishmaniasis mexicana. Consideraciones epidemiológicas, clínicas y terapéuticas para el médico general. Rev Sanid Milit Mex 1997;51(1):46-51.

6. Ortega-Parres G, López-Antuño F. Taller internacional sobre epidemiología molecular: Propuestas del grupo interdisciplinario sobre T. americana y leishmaniasis. Gac Med Mex 1997;133 (1):49-62.

7. Villalobos S. Un caso de úlcera de los chicleros en la ciudad de Tehuantepec, Oax. Pasteur 1933;6(2):92.

8. Millán-Gutiérrez J, González A. Leishmaniasis cutánea infantil. Rev Med Hosp Gen 1944;6(9):153-62.

9. Biagi F, Marroquín F, González A. Distribución geográfica de la leishmaniasis cutánea en México: hallazgo de una nueva área endémica. Medicina Mex 1957;780:444-6.

10. Latapí F. Botón de Oriente en México. Dermatol Ibero Latino-Americana 1966;8(1):45-54.

11. Andrade-Narváez M, Vargas-González A, Canto-Lara SB, et al. Clinical picture of cutaneous leishmaniasis due to Leishmania (Leishmania) mexicana in the Yucatan peninsula, Mexico. Mem Inst Oswaldo Cruz 2001;96:163-7.

12. Andrade-Narváez FJ, Simmonds-Diaz E, Rico-Aguilar S, et al. Incidence of localized cutaneous leishmaniasis (chiclero’s ulcer) in Mexico. Trans R Soc Trop Med Hyg 1990;84:219-20.

13. Herwaldt BL. Leishmaniasis. Lancet 1999;354:1191-9.

14. Magill AJ. Cutaneous leishmaniasis in the returning traveler. Infect Dis Clin North Am 2005;19:241-66.

15. Berman JD. Human leishmaniasis: clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997;24:684-703.

16. Bravo F, Sánchez MR. New and reemerging cutaneous infectious diseases in Latin America and other geographic areas. Dermatol Clin 2003;21:655-8.

17. Hepburn NC. Management of cutaneous leishmaniasis. Curr Opin Infect Dis 2001;14:151-4.

18. Markle WH, Makhoul K. Cutaneous leishmaniasis: recognition and treatment. Am Acad Fam Physic 2004;69(6):1-10.

19. Saenz RE, Paz H, Berman JD. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am J Med 1990;89:147-55.

20. Panagiotopoulos A. Treatment of cutaneous leishmaniasis with cryosurgery. Int J Dermatol 2005;44(9):749-52.